Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81330005-81394179	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 49.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037723, HPA037724"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037723: AB_10672606, HPA037724: AB_2675631"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.2	49.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.4	0.0	0.0	0.6	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.4	15.4	19.5	45.7	17.1	34.5	9.9	12.7	40.6	15.7	22.3	17.9	21.1	22.9	28.5	16.1	16.3	20.6	23.5	20.2	43.3	39.6	30.3	26.4	38.0	25.8	21.6	40.2	32.3	39.4	29.6	12.0	32.5	20.0	11.9	32.4	13.2	23.7	53.3	16.3	37.4	26.1	47.1	48.6	22.5	26.0	15.0	16.9	67.5	24.7	31.3	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.4	29.9	19.1	15.5	39.5	6.7	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1	44.7	49.4	132.5	80.9	43.7	20.8	32.3	96.8	60.2	53.4	75.0	35.3	93.6	154.2	163.4	4.1	51.7	130.2	0.0	136.9	121.2	79.9	92.3	108.6	269.4	347.1	15.9	113.6	74.9	110.8	5.9	63.3	159.5	77.6	161.5	133.1	26.5	118.5	151.9	52.6	1001.5	34.9	6.5	49.5	3.2	27.2	41.0	56.8	53.3	166.2	98.2
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.5	122.4	13.8	19.5	59.5	16.2	36.8	13.1	224.5	19.3	25.0	5.6	12.4	0.0	6.1	21.9	85.2	5.7	15.0	13.1	15.4	4.8	13.7	6.9	18.4	16.6	85.3	0.0	0.0	15.1	9.8	27.6	7.3	18.9	27.2	13.6	0.0	4.6	21.3	0.2	20.3	9.3	22.9	0.9	0.1	21.2	8.8	10.2	106.2	66.2	10.3	22.9	91.9	0.1	9.6	9.4	0.0	10.3	21.4	19.1	8.9	1.7	14.2	12.6	13.9	34.2	101.0	0.0	11.4	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9	11.9	23.7	50.6	46.4	18.3	34.0	127.0	30.6	24.1	23.9	615.9	7.9	969.9	139.3	102.5	3.0	53.2	0.7	0.0	35.6	1080.2	76.5	15.6	52.0	1.3	331.4	68.3	29.7	89.6	135.4	11.5	73.4	69.6	28.7	93.8	13.6	46.3	62.2	5.8	72.9	43.7	20.2	58.2	30.9	20.7	70.9	10.2	1691.2	45.4	5.0	37.4
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312146	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Proximal tubular cells: 516.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	Cytosol		NA	NA		2700000	Cytosol		"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: AB_2685307"	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.59e-4)"	21.2	39.0	25.2	14.0	26.9	15.2	22.0	19.8	26.2	32.9	38.5	28.1	28.7	56.0	20.2	23.0	25.7	35.1	31.9	31.2	22.0	19.4	49.3	32.4	14.4	21.9	24.9	26.2	31.6	60.8	14.8	19.0	17.2	23.6	19.9	19.5	25.8	21.4	24.9	33.8	18.8	43.1	20.8	20.0	16.3	22.3	21.6	21.4	24.7	22.9	20.2	18.3	16.7	21.6	23.0	40.1	13.7	29.0	22.2	27.1	23.5	24.1	15.3	16.8	15.5	26.6	25.9	11.2	18.1	22.2	25.4	22.9	19.4	20.5	17.5	19.4	24.3	14.3	19.3	18.7	27.2	12.1	13.9	29.7	11.0	14.8	31.0	20.7	12.1	8.9	25.8	21.5	19.5	12.0	24.1	21.5	23.1	16.0	16.5	26.0	24.1	23.5	11.8	4.8	34.0	19.3	24.8	21.0	30.9	24.7	10.7	31.6	11.8	19.7	17.9	30.4	10.0	35.5	42.3	16.8	15.9	16.9	17.1	13.5	20.1	12.6	21.4	34.4	27.9	22.4	0.1	29.0	13.7	23.0	23.7	26.8	23.0	20.7	20.3	40.1	21.4	23.9	20.6	3.4	22.2	17.8	35.0	27.1	23.5	25.2	26.9	19.8	26.2	22.0	19.4	24.9	26.2	23.6	21.4	14.9	21.1	39.8	56.3	21.6	32.8	23.2	94.3	28.1	11.4	73.3	5.9	113.3	215.5	57.4	69.6	30.0	128.4	23.3	32.2	83.3	55.7	48.3	10.3	81.5	89.0	20.6	95.6	38.1	55.4	39.4	71.7	32.8	50.6	63.1	87.2	111.7	40.7	123.6	63.6	516.4	22.5	45.3	39.1	63.0	23.2	29.7	85.8	48.1	129.1	48.9
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 58.2;Paneth cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.3	17.4	16.8	44.0	22.6	21.8	18.1	21.5	32.3	21.9	27.6	34.9	14.7	62.6	20.1	33.8	10.6	24.4	33.6	22.1	24.9	17.7	26.4	19.8	12.4	49.5	14.8	34.6	22.2	22.9	13.6	17.8	34.9	36.4	22.9	23.6	18.5	13.2	16.3	26.4	31.2	22.3	19.8	30.5	17.4	29.4	19.2	21.4	25.5	14.0	16.8	16.6	17.1	13.6	15.8	20.1	20.3	16.2	18.9	9.1	14.5	23.4	24.6	15.3	11.3	38.3	17.7	40.1	11.6	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4	6.0	8.6	11.5	6.6	10.0	5.7	4.3	10.2	16.0	14.8	19.2	0.0	36.1	1.7	12.5	0.7	5.4	58.2	0.0	18.4	25.8	17.5	15.6	8.1	23.1	10.1	9.5	19.0	4.9	3.2	0.4	8.6	3.1	15.1	2.8	37.5	5.2	12.4	54.7	11.3	7.9	2.8	0.0	5.6	5.1	9.0	7.0	25.3	8.7	30.7	8.1
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 117.2;Ductal cells: 60.1;Extravillous trophoblasts: 40.0;Hepatocytes: 113.4;Proximal tubular cells: 118.8;Undifferentiated cells: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 55.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA		210000	Mitochondria	"Nucleoplasm, Vesicles, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	21.5	20.1	6.2	9.9	8.8	10.5	5.0	10.3	5.2	8.7	9.0	13.4	4.2	13.6	6.2	14.5	13.2	3.0	20.4	21.9	8.7	15.2	8.8	6.7	14.8	39.8	6.4	10.7	7.6	12.5	4.8	7.1	6.2	17.9	8.3	3.3	19.4	13.4	13.2	8.2	0.0	4.3	18.4	55.5	9.0	4.4	37.6	10.4	7.8	9.7	13.6	6.3	7.9	5.2	6.0	6.8	4.9	8.4	5.6	10.1	16.7	8.4	12.9	2.0	3.9	5.4	5.2	11.0	6.8	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7	8.9	1.7	3.6	3.8	0.9	1.3	5.6	117.2	0.0	3.4	15.7	2.0	1.3	14.9	60.1	0.5	3.8	7.0	0.0	5.9	40.0	6.2	2.9	9.2	113.4	6.5	0.0	15.0	9.8	3.8	1.3	6.1	4.0	0.0	7.2	16.9	1.3	14.2	3.5	6.3	118.8	0.3	0.0	9.5	0.3	0.6	0.9	1.5	2.9	68.9	2.6
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 770.8;monocytes: 1397.7;Proximal tubular cells: 645.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.4;HHSteC: 28.4;OE19: 41.9;SK-BR-3: 57.1;THP-1: 25.4"									HPA051065	Approved					NA	NA		1400000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.6	5.3	9.1	25.4	3.8	17.4	2.6	4.7	1.2	0.9	6.5	3.4	0.1	13.0	5.7	3.4	4.5	0.0	1.3	0.7	0.1	1.7	0.2	2.3	17.6	28.4	0.2	0.2	6.9	6.5	4.2	0.1	5.1	7.6	0.2	4.8	0.8	1.1	0.1	0.2	6.3	7.0	41.9	0.6	0.1	0.1	0.5	8.8	0.1	2.1	6.6	6.4	57.1	0.0	10.1	5.7	25.4	0.3	0.1	4.8	0.1	0.1	1.5	0.8	6.9	6.3	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8	137.0	197.2	37.4	126.5	53.2	67.9	333.7	140.1	95.0	178.6	62.8	17.7	50.7	338.2	110.9	3.4	72.6	272.6	70.0	195.0	101.4	59.3	72.9	29.0	770.8	132.7	33.4	53.0	106.2	211.9	7.0	73.9	169.3	33.7	1397.7	184.2	107.6	110.7	325.4	140.0	645.3	34.9	45.3	77.3	2.7	3.2	109.0	35.2	13.8	218.4	82.3
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19677598	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.6;OE19: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Approved					NA	NA					"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	22.3	66.4	8.5	9.0	24.6	2.8	10.0	8.8	12.8	13.7	15.9	17.5	7.5	15.6	13.5	19.2	39.6	10.7	26.4	12.5	9.5	6.5	52.5	88.6	17.7	4.3	11.1	10.3	13.5	24.4	10.1	14.9	3.1	14.4	20.7	11.1	16.2	26.0	10.0	18.5	57.1	26.6	10.5	10.2	8.0	18.3	9.8	15.4	4.5	27.3	27.9	22.5	9.8	17.0	3.9	14.3	11.6	14.2	8.6	6.4	5.7	5.7	35.6	3.6	8.9	17.0	14.3	2.5	1.7	4.3	3.4	3.8	11.1	9.2	1.8	4.1	7.0	5.9	12.7	14.0	17.1	2.4	7.9	6.1	0.9	18.7	27.2	3.2	4.2	0.4	7.9	24.3	3.1	1.9	8.9	6.7	4.8	0.2	0.0	8.5	7.7	0.1	5.2	8.5	66.4	19.5	4.1	10.2	5.4	3.9	18.0	6.9	4.9	15.5	6.0	4.9	22.9	10.4	3.9	7.9	2.2	4.0	5.7	5.3	2.4	6.0	2.5	10.5	0.0	7.0	0.0	14.2	11.6	4.2	12.6	6.4	3.9	4.3	3.7	14.3	3.0	4.9	3.4	0.7	8.6	13.7	0.2	5.8	5.7	8.5	24.6	8.8	12.8	9.5	6.5	11.1	10.3	14.4	15.4	163.8	69.7	11.9	106.4	50.7	13.8	39.2	104.4	69.6	113.7	31.4	11.8	10.6	36.5	84.4	78.7	15.8	49.7	0.0	45.0	3.4	27.7	87.9	27.8	102.6	23.4	6.4	15.5	14.1	16.7	14.7	51.8	24.2	6.8	21.6	25.0	98.7	45.1	28.1	75.7	88.8	20.1	12.9	14.6	10.4	22.6	78.9	1.1	13.8	36.8	28.6
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 39.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9"	"Cell line enhanced"	"Detected in many"		"A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038525	Uncertain					NA	NA					"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	9.1	9.8	1.8	5.0	2.5	21.4	2.4	1.3	2.3	6.2	7.8	4.2	1.1	11.8	4.0	7.0	4.0	21.0	13.7	3.1	2.6	2.4	9.3	5.1	28.5	14.3	4.3	1.4	6.6	12.9	0.0	3.8	13.4	3.8	4.6	3.1	7.8	5.7	2.0	2.0	1.8	21.4	4.2	5.6	11.7	10.4	2.9	1.9	0.7	1.7	1.5	3.3	7.6	3.8	0.1	17.6	39.8	32.9	2.9	0.1	9.8	3.3	45.0	0.3	0.9	3.0	9.6	8.1	4.6	7.6	3.3	1.6	1.6	46.3	0.2	8.2	10.6	4.7	3.8	0.1	0.6	0.8	0.1	0.3	0.4	18.1	3.9	19.1	2.6	0.1	7.0	2.0	1.6	4.5	7.5	0.1	0.2	0.1	8.2	5.3	2.7	0.2	2.5	0.3	22.4	2.7	1.0	1.8	24.7	5.4	0.4	0.5	0.2	10.6	8.9	4.4	0.2	10.3	5.8	5.1	4.8	6.7	23.1	1.5	0.1	0.8	0.0	27.3	7.3	2.2	11.8	23.0	39.8	0.0	32.9	0.1	0.1	0.0	0.0	17.6	0.1	0.0	0.0	6.9	2.9	29.1	1.8	0.0	9.8	1.8	2.5	1.3	2.3	2.6	2.4	4.3	1.4	3.8	1.9	107.2	53.7	0.9	2.6	1.9	0.5	2.4	17.8	265.0	76.2	5.2	0.0	0.7	0.0	4.9	18.4	1.9	11.7	0.0	2.2	6.7	8.2	2.5	23.3	2.0	31.5	3.2	2.4	1.3	54.8	7.6	1.7	31.3	3.3	8.2	10.0	2.0	11.4	7.0	1.4	20.0	0.4	0.0	4.2	0.2	0.2	0.9	0.6	0.0	10.0	4.4
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	10	"Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"MCF7: 31.6;SK-BR-3: 32.7"					"Not detected"	"Not detected"			HPA045132	Approved					NA	NA					"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	2.6	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	32.7	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.9	0.0	1.5	1.4	0.0	0.3	0.0	0.0	0.0	5.2	0.0	8.5	1.7	0.3	0.0	0.0	0.0	0.0	0.2	8.0	0.4	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.2	0.0	0.0	6.2
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 313.9;Proximal tubular cells: 167.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6;SK-BR-3: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		40000	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.1	8.0	4.1	12.1	17.4	2.6	10.0	4.9	3.0	5.1	4.1	5.8	3.8	3.4	6.6	6.4	2.4	13.8	6.9	14.7	1.9	1.9	6.1	1.9	1.9	34.6	5.5	1.7	6.2	6.7	8.2	2.8	2.8	3.8	5.7	5.8	7.7	2.5	3.4	13.2	1.7	8.3	2.0	10.6	4.1	10.7	3.4	4.0	5.3	13.0	8.1	3.1	8.7	35.8	6.4	6.5	16.3	2.6	4.7	4.4	5.8	5.3	1.7	2.8	6.6	1.0	1.6	13.5	5.8	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6	0.0	3.2	7.2	14.0	6.6	3.1	18.5	38.2	1.4	0.0	43.6	9.8	61.1	39.7	5.6	0.4	2.7	0.4	0.0	0.8	7.2	2.3	9.5	4.6	313.9	11.9	19.1	2.4	16.5	14.0	0.4	1.1	1.4	3.3	17.2	2.9	10.8	2.9	1.5	2.5	167.5	4.2	6.5	4.3	2.1	3.6	4.6	72.4	2.2	3.3	9.7
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494852-24537207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 62.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 41.1;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		44000	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	5.8	4.8	23.7	8.3	27.4	3.1	4.1	13.5	21.5	4.1	6.0	9.5	1.2	7.7	3.9	3.1	5.6	13.5	4.4	9.8	17.3	21.0	18.4	62.6	5.0	8.9	16.0	14.7	5.8	6.6	11.4	4.5	2.2	13.0	6.2	5.7	4.1	3.9	4.3	31.1	6.9	5.4	2.8	10.9	4.8	5.2	3.7	8.8	21.4	12.1	4.9	8.8	6.3	5.5	3.9	3.8	0.4	0.2	1.6	6.8	1.2	3.2	3.0	2.1	3.2	0.0	0.0	3.5	0.3	0.6	0.8	0.5	11.7	0.8	41.1	6.2	0.3	0.7	0.0	3.4	0.4	0.5	4.2	5.7	6.4	1.9	13.4	0.5	9.9	0.8	0.3	1.6	0.1	0.0	2.3	0.0	11.3	3.2	0.0	0.6	7.6	12.0	5.9	0.8	5.8	1.5	13.9	0.6	0.4	2.5	6.6	3.7	3.3	3.8	0.4	4.0	0.9	5.9	5.4	0.0	0.4	2.1	0.1	2.1	5.8	8.6	51.4	0.0	3.1	0.4	0.4	0.1	0.2	1.7	0.0	3.3	3.7	2.4	2.8	0.2	3.9	6.8	5.7	0.4	1.6	0.2	3.8	1.6	1.2	23.7	27.4	13.5	21.5	17.3	21.0	16.0	14.7	13.0	8.8	14.9	22.3	8.8	4.6	1.4	10.6	29.9	5.1	13.4	9.1	7.0	15.7	5.0	1.7	1.8	0.5	3.1	8.4	23.3	0.8	4.3	2.1	5.1	6.9	85.5	3.2	15.9	8.1	6.7	3.8	0.0	3.1	2.0	1.7	0.0	10.5	10.4	1.3	3.5	4.2	24.0	6.5	0.0	1.6	1.4	6.1	2.6	1.6	5.4	16.7	11.5
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 453.8;Proximal tubular cells: 730.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.9	10.2	9.2	3.2	6.1	3.5	6.0	9.1	5.2	5.4	7.2	6.9	2.9	2.7	13.0	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.8	1.3	1.2	15.0	6.6	4.5	11.4	9.2	6.2	12.2	4.0	7.5	2.4	17.8	3.7	2.0	4.5	17.2	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	10.1	29.7	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.2	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7	35.7	48.4	23.6	21.0	8.1	17.6	73.0	48.4	25.4	29.6	62.8	3.9	22.5	170.8	8.1	19.8	13.5	22.3	0.0	2.7	12.8	13.1	38.6	7.0	453.8	14.9	11.1	16.3	58.3	22.2	15.8	26.7	9.0	23.6	20.8	37.9	90.4	5.6	10.5	45.3	730.1	15.1	12.9	21.7	10.5	3.9	6.5	25.6	6.9	37.0	15.2
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 364.8;Proximal tubular cells: 241.4;Syncytiotrophoblasts: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		140000	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	15.0	10.0	28.3	46.8	23.5	14.0	36.1	18.1	22.4	21.1	27.2	28.0	14.5	0.0	18.5	14.1	8.8	11.3	8.8	61.1	19.4	0.0	10.6	2.9	14.9	23.8	11.5	0.0	0.0	17.1	14.4	16.4	11.8	15.6	16.8	0.0	0.0	0.0	18.5	9.9	0.6	0.0	19.1	11.1	8.5	9.0	32.1	0.0	20.0	11.5	9.6	11.5	0.0	10.0	10.5	22.7	18.0	0.6	20.4	6.1	18.9	7.0	12.4	0.0	0.0	0.0	3.3	0.0	9.8	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4	14.9	24.0	11.8	48.6	23.0	22.4	35.5	25.5	20.1	33.0	40.1	21.6	364.8	64.6	31.9	24.9	14.7	17.8	0.0	12.1	88.6	30.8	28.6	6.9	69.5	42.5	23.8	20.8	20.9	9.4	29.5	23.6	7.4	52.3	12.6	22.1	96.8	15.1	8.6	35.0	241.4	12.2	19.4	17.3	1.0	3.1	14.1	185.9	2.5	43.7	34.8
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 289.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.0	16.7	15.6	14.0	49.9	44.0	13.1	22.6	32.1	22.8	19.8	10.3	12.8	0.0	21.7	20.2	11.2	13.5	12.6	22.1	27.0	7.9	16.0	10.9	12.0	11.2	25.7	17.0	11.6	28.2	11.2	24.1	20.2	31.6	19.7	14.5	17.2	15.4	35.4	10.2	11.3	17.6	22.7	44.9	20.5	9.7	19.8	22.8	29.6	16.2	18.6	12.8	16.1	18.2	20.7	22.1	34.6	25.9	19.4	13.8	13.5	16.7	11.4	14.4	18.7	17.0	15.5	16.3	13.2	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5	14.9	37.5	27.9	34.1	29.0	24.6	38.9	48.4	69.6	30.7	48.8	21.6	42.9	82.9	36.4	32.5	37.9	44.4	23.3	32.5	64.2	46.7	49.5	36.9	114.6	53.7	12.7	53.6	52.8	58.2	28.9	88.3	37.5	54.0	19.8	52.5	289.8	28.8	31.6	108.5	141.7	26.8	25.8	36.0	33.8	46.2	45.4	31.9	38.9	58.1	23.5
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361913	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 162.5;Proximal tubular cells: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"	NA	NA					"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	13.0	39.6	14.3	15.6	20.1	3.8	15.2	22.5	20.7	14.1	19.8	10.5	25.3	19.2	11.1	16.0	8.9	10.7	11.4	30.4	15.4	19.7	50.4	21.3	9.7	6.7	19.1	9.0	11.8	20.7	27.0	10.1	13.1	16.3	23.8	14.4	10.6	20.1	35.4	31.0	6.7	16.0	10.4	15.2	7.7	17.7	6.1	12.1	9.1	17.5	11.8	8.9	10.2	10.5	8.7	5.8	16.1	4.6	9.9	10.0	5.3	4.6	4.5	6.3	3.2	7.9	8.5	9.8	4.1	5.2	3.2	3.7	2.5	5.9	5.4	4.3	4.4	9.7	6.8	9.4	5.2	4.6	41.8	8.0	3.7	4.9	15.0	6.0	5.3	3.9	7.0	6.6	2.6	9.0	7.6	3.9	5.6	5.1	8.2	3.8	4.4	7.3	12.0	7.9	11.3	6.5	4.3	5.1	9.3	14.1	2.5	6.5	4.7	6.2	14.9	7.8	15.1	2.7	3.5	4.0	3.2	4.1	4.7	4.0	9.4	7.9	1.8	5.1	4.3	2.2	15.2	4.6	16.1	6.9	3.2	7.9	7.8	7.6	10.0	4.2	8.7	9.6	8.8	7.1	9.9	2.1	5.8	9.3	5.3	14.3	20.1	22.5	20.7	15.4	19.7	19.1	9.0	16.3	12.1	0.0	7.7	5.2	22.9	4.6	17.8	32.7	28.1	13.4	4.5	26.2	23.6	37.5	162.5	21.0	2.6	11.2	33.1	23.3	14.0	23.8	11.3	45.7	1.1	16.0	11.6	12.7	22.0	11.1	9.4	1.0	13.3	7.6	11.8	44.1	16.4	8.5	13.9	23.7	10.6	92.2	32.2	12.9	7.5	9.4	11.7	3.6	30.4	13.1	23.0	22.0
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 56.2;Early spermatids: 65.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	14.0	13.0	13.2	5.5	22.5	7.2	13.1	14.1	16.8	10.5	7.9	14.0	12.8	6.5	10.9	17.0	7.9	28.2	9.4	13.9	14.4	12.0	19.2	13.0	8.8	4.7	9.4	13.5	14.6	13.1	9.7	18.1	7.0	16.5	11.0	7.8	11.7	10.5	13.2	9.9	10.1	6.0	9.4	6.5	5.9	8.4	14.5	11.7	6.9	22.8	8.6	5.6	7.4	7.5	3.4	3.1	2.7	2.3	1.6	5.9	1.8	16.1	12.0	5.8	15.4	10.4	9.3	3.5	8.3	8.3	9.0	8.6	7.6	3.1	7.0	5.9	6.7	5.3	14.5	12.8	10.9	13.5	4.6	14.7	4.6	15.7	10.8	4.7	8.1	3.3	7.8	13.8	15.6	14.1	5.5	9.5	17.1	3.3	4.8	4.9	7.0	12.6	3.3	7.3	10.5	12.5	8.7	2.7	7.0	14.1	3.1	7.9	5.3	13.2	7.4	7.6	6.2	8.7	3.3	6.6	7.0	6.1	12.2	10.5	2.5	6.1	3.9	14.5	4.5	4.4	0.5	2.3	0.1	2.7	1.9	3.3	3.4	2.4	1.4	3.1	1.5	5.9	3.1	2.7	1.6	1.1	1.4	2.2	1.8	13.2	22.5	14.1	16.8	14.4	12.0	9.4	13.5	16.5	11.7	11.9	24.5	1.9	4.1	4.5	4.2	0.2	10.2	56.2	15.9	5.2	19.6	3.6	11.6	3.6	65.5	6.8	5.1	0.0	2.7	2.1	5.3	8.0	10.4	7.6	3.4	1.6	5.8	6.2	1.0	34.0	4.4	4.0	5.0	0.0	7.5	6.8	5.2	3.5	3.5	9.6	18.0	6.5	3.8	2.8	2.5	5.4	2.2	1.3	7.6	1.6
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703141	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 249.9"	"Low region specificity"	"Detected in all"							"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1600000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	22.2	30.5	42.1	19.5	42.3	11.4	32.0	25.4	42.3	27.1	42.1	19.7	22.9	48.1	25.3	49.2	28.2	31.5	17.8	39.2	37.8	37.7	37.1	65.3	30.7	31.6	38.9	29.7	37.6	25.9	33.2	12.6	26.7	40.6	74.0	22.7	21.7	21.7	28.2	57.5	31.3	64.3	28.9	37.6	25.6	21.3	12.9	21.4	19.8	32.6	42.5	24.3	28.6	24.7	25.9	28.6	8.5	15.6	10.8	24.4	14.7	18.5	8.6	24.8	24.6	11.8	21.3	21.9	16.2	15.4	22.8	23.8	20.9	7.1	20.7	12.8	12.9	27.2	12.3	21.2	20.9	28.9	18.8	32.7	30.6	11.1	19.5	17.7	11.6	249.9	18.2	12.9	21.6	15.5	14.9	24.6	14.7	24.1	13.8	21.3	15.7	18.1	14.8	17.8	16.6	16.9	15.8	30.0	13.5	20.8	14.1	19.3	19.5	11.4	15.9	30.5	17.8	18.4	58.4	10.1	17.8	16.4	15.4	25.6	10.9	20.5	56.8	6.4	30.1	28.5	8.5	9.8	6.9	18.0	15.6	24.4	24.7	18.1	18.3	18.3	25.9	17.1	17.9	1.2	10.8	12.1	28.6	15.7	14.7	42.1	42.3	25.4	42.3	37.8	37.7	38.9	29.7	40.6	21.4	122.1	136.6	86.9	79.7	57.5	55.3	121.3	48.4	88.3	91.0	85.5	19.6	91.3	210.5	107.2	3.6	70.9	36.2	0.0	64.3	264.4	68.8	192.8	67.2	86.8	68.4	65.2	35.1	200.1	112.1	4.7	77.6	69.2	99.5	129.8	41.3	160.8	66.2	35.7	103.3	107.3	50.7	45.3	65.9	11.9	15.7	77.0	61.2	59.9	55.5	125.1
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Cytosol		NA	NA		3800000	Cytosol		"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	21.7	29.5	31.3	16.7	35.6	10.2	19.1	26.0	36.2	17.8	37.1	21.5	16.5	43.0	22.3	23.3	23.6	24.9	20.9	19.7	26.1	38.5	41.6	40.4	16.8	22.8	23.0	34.8	22.9	32.3	13.9	19.4	28.1	28.6	21.1	26.6	21.9	29.2	20.9	21.4	27.5	42.5	24.7	18.2	23.8	43.4	17.9	18.2	22.7	26.0	19.2	24.0	25.2	17.5	27.5	17.9	17.8	24.6	22.8	36.7	26.0	40.2	36.5	42.2	23.3	18.5	18.5	25.8	32.3	19.9	26.2	20.0	29.6	28.9	48.1	35.3	14.5	24.5	29.2	36.7	20.5	27.5	35.2	31.4	23.2	20.3	38.6	18.4	23.8	30.7	12.9	28.6	26.3	23.2	16.8	24.2	40.1	37.8	31.4	27.6	24.9	40.9	18.4	30.8	40.0	12.5	41.0	17.1	22.0	25.9	27.6	19.2	32.3	25.6	18.6	41.4	27.7	23.1	25.4	31.4	25.1	20.1	35.0	40.4	17.7	32.1	29.6	29.8	26.9	26.1	9.2	19.8	17.8	27.7	24.2	30.2	27.0	33.6	33.3	17.5	27.5	28.7	31.3	2.7	22.8	24.6	17.9	36.7	26.0	31.3	35.6	26.0	36.2	26.1	38.5	23.0	34.8	28.6	18.2	53.6	32.8	19.4	36.9	42.6	36.9	27.0	50.9	66.9	60.3	96.0	27.5	93.5	150.9	67.8	30.1	37.6	47.9	0.0	50.6	68.7	47.3	35.9	38.3	57.2	70.9	12.7	27.7	25.8	28.8	47.7	35.9	49.1	64.1	76.7	46.8	36.9	50.1	59.6	43.9	135.3	35.1	45.3	41.9	16.9	26.8	47.9	57.8	47.3	57.4	35.3
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 748.4;Proximal tubular cells: 664.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022971, HPA078575"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975, HPA078575: "	"prognostic favorable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.9	46.2	26.2	23.9	24.1	26.8	26.5	25.6	34.0	35.0	38.1	17.4	13.9	30.7	15.1	30.0	26.2	14.5	15.0	33.4	20.9	41.0	18.8	18.0	43.0	30.9	38.1	17.1	18.7	31.9	29.4	20.2	26.1	29.6	30.3	21.0	32.9	12.7	30.7	24.5	16.6	17.6	15.9	29.2	20.1	16.4	19.2	17.0	46.6	18.2	10.9	19.6	22.0	42.1	23.9	24.7	23.7	22.1	32.9	19.2	30.9	13.3	22.1	10.1	7.7	20.5	27.3	9.9	28.1	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7	53.6	20.9	43.5	39.7	38.5	33.3	86.0	219.1	29.4	26.1	48.8	19.6	128.8	210.5	67.4	10.2	41.4	82.6	46.7	77.8	76.0	63.3	42.0	49.6	748.4	97.6	22.3	59.7	76.1	83.4	10.4	69.0	49.3	75.9	86.6	59.5	85.7	64.8	60.5	92.6	664.7	23.4	77.6	62.6	17.5	16.2	49.2	74.4	37.9	71.9	35.2
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827194	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.4"	"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					NA	NA		3000000			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favorable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favorable (5.19e-4)"	14.8	36.9	24.9	7.8	26.7	26.2	16.4	26.8	35.3	9.7	12.9	13.6	19.6	17.6	6.8	13.0	11.7	11.8	9.9	50.9	28.0	24.5	38.8	91.4	14.5	8.5	23.2	24.5	6.3	24.6	17.1	19.7	9.2	18.5	12.4	9.5	11.9	12.5	16.2	67.1	11.0	17.1	11.7	20.7	10.1	13.1	33.8	13.7	7.4	14.1	18.3	7.2	9.7	18.2	13.7	28.9	27.7	36.5	10.9	18.3	12.5	11.5	17.5	15.8	17.9	13.9	5.5	14.3	14.5	13.5	22.4	18.1	9.0	10.1	2.4	29.8	12.4	15.4	12.6	15.0	14.5	6.7	23.9	24.1	4.4	17.9	25.6	20.0	5.8	24.3	6.7	31.2	11.2	7.7	19.8	19.2	30.4	5.8	21.7	7.0	19.0	15.0	12.6	6.0	11.9	16.2	12.7	10.0	27.2	28.7	5.2	21.3	18.4	15.9	20.4	31.1	12.5	15.0	19.5	14.6	6.8	8.5	14.2	16.6	24.6	23.2	7.1	11.6	5.4	10.9	14.4	15.3	27.7	12.6	25.8	9.2	13.7	16.2	12.9	13.7	12.4	15.8	13.2	13.5	10.9	36.5	28.9	18.3	12.5	24.9	26.7	26.8	35.3	28.0	24.5	23.2	24.5	18.5	13.7	8.9	32.9	46.9	39.2	21.2	110.6	73.4	58.6	26.8	11.4	43.6	60.9	45.4	134.3	38.1	141.4	30.0	81.5	280.4	33.8	33.2	26.9	51.0	30.0	169.8	67.1	130.3	38.1	41.7	39.3	41.7	43.4	47.0	52.3	57.7	36.1	79.2	45.7	70.2	51.6	487.6	102.8	71.1	36.8	224.6	49.5	39.9	57.4	54.2	35.0	42.0
HAGHL	MGC2605	ENSG00000103253	"Hydroxyacylglutathione hydrolase like"	Q6PII5	16	726936-735525	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 50.9;Ciliated cells: 34.8;Distal tubular cells: 29.9;Hofbauer cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 30.0;U-266/70: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074402	Approved					NA	NA					"HPA074402: AB_2732254"	"unprognostic (6.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.56e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.92e-2)"	"unprognostic (5.36e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.41e-1)"	2.7	8.7	10.0	6.2	19.7	4.5	1.2	13.0	15.5	1.7	2.1	9.4	2.5	2.9	3.7	2.7	1.1	7.9	2.6	5.3	10.6	10.9	4.9	1.4	4.0	8.3	15.9	6.7	1.4	2.4	5.8	8.1	2.3	10.7	2.6	0.9	4.5	9.6	4.0	1.3	2.7	4.5	1.1	13.9	8.4	5.8	3.5	9.1	2.9	0.9	1.6	3.8	1.8	1.0	13.1	3.7	1.3	1.5	8.5	7.2	3.1	2.1	2.3	0.6	3.1	0.5	1.1	2.4	2.0	1.3	0.4	0.5	1.0	3.0	4.9	3.0	0.1	0.8	2.9	0.5	0.8	0.0	14.3	2.0	1.6	5.4	1.8	3.7	6.1	4.6	2.1	0.8	0.0	1.0	1.3	0.3	4.9	2.8	4.4	0.6	14.6	0.1	8.6	3.3	3.6	5.1	3.2	1.4	30.0	1.2	0.7	11.3	6.7	1.0	8.8	9.3	0.1	5.5	10.7	1.9	2.4	3.6	0.8	1.2	32.2	4.1	6.8	3.8	6.2	4.3	0.0	1.5	1.3	6.2	0.5	7.2	13.1	4.1	6.8	1.9	3.5	1.2	4.6	0.0	8.5	0.2	3.7	4.7	3.1	10.0	19.7	13.0	14.1	10.6	10.9	15.9	6.7	10.7	9.1	3.0	1.1	11.5	1.9	1.0	50.9	10.1	0.0	34.8	3.4	3.5	0.0	0.4	29.9	2.8	4.3	0.6	0.0	0.0	0.0	1.0	2.4	4.9	8.1	0.6	34.5	11.1	3.5	0.6	5.4	9.1	6.4	7.2	18.6	6.4	1.1	10.3	2.2	0.3	5.6	6.9	7.8	0.0	2.0	7.5	6.5	0.3	0.3	10.2	1.4	0.6
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 1952.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	80.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	189.0	66.1	31.6	48.6	48.0	131.1	34.9	70.0	53.9	19.8	43.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	50.2	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9	68.5	191.6	171.4	331.5	1952.6	415.5	222.7	142.7	85.6	187.7	293.1	137.4	475.1	368.1	1059.9	147.3	475.2	671.1	0.0	1350.8	1780.5	725.6	281.3	256.4	438.3	607.6	486.3	43.8	182.3	215.4	106.3	266.3	427.9	1116.8	1462.6	176.8	316.6	1380.9	487.5	192.7	408.8	354.8	187.5	1239.9	102.9	38.5	1506.3	419.6	213.6	251.8	384.9
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479600	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	6	"Early spermatids: 7.5;Late spermatids: 5.6;Spermatocytes: 4.6;Spermatogonia: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HL-60: 15.6"															NA	NA						"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.4	0.6	1.4	0.2	2.4	1.9	0.1	0.2	0.4	0.0	0.9	0.2	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.4	0.2	0.2	0.6	0.3	0.7	0.7	0.4	0.0	0.4	0.2	2.2	0.2	0.1	1.9	0.3	0.3	0.2	1.5	0.8	0.0	0.3	0.4	0.4	18.9	0.0	0.1	0.8	0.0	0.1	0.2	0.2	1.3	0.7	3.5	0.5	1.6	1.9	0.2	0.2	0.4	1.0	0.8	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.5	0.9	0.3	0.0	0.2	0.6	0.1	0.3	0.4	0.7	1.0	0.6	0.9	0.5	0.0	15.6	0.7	0.1	0.3	0.0	0.2	0.2	0.0	1.0	0.4	1.2	0.1	0.3	0.4	1.1	0.4	0.2	0.7	0.8	0.4	1.5	0.1	1.1	0.6	0.5	0.5	0.3	0.2	0.5	0.4	2.2	0.8	0.6	0.2	1.0	0.3	2.7	0.6	0.2	0.3	0.6	0.3	2.1	0.4	0.4	1.9	0.3	0.3	0.9	0.5	0.5	0.7	1.3	1.1	1.0	3.5	1.6	0.5	0.5	1.3	0.2	0.6	0.6	2.4	1.9	0.4	0.5	0.3	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.6	0.0	0.0	4.6	3.6	0.0	0.2	0.0	0.0	0.0
LDHAL6B	"LDH6B, LDHAL6, LDHL"	ENSG00000171989	"Lactate dehydrogenase A like 6B"	Q9BYZ2	15	59206823-59208515	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 56.6"	"Cell type enriched"	"Detected in some"	20	"Spermatocytes: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4"	"Region enriched"	"Detected in single"	6	"olfactory region: 1.7"					HPA053962	Enhanced					NA	NA					"HPA053962: AB_2682324"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.53e-2)"	"unprognostic (7.80e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	56.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.0	0.4	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	1.5	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.0	0.0	0.4	0.4	0.8	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	103.7	0.6	0.0	0.0	0.0	0.0	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 2212.6;Distal tubular cells: 2801.9;Proximal tubular cells: 2766.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol		No	No		780000000	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.6	87.5	77.0	50.6	55.2	61.5	89.5	45.6	45.6	63.8	63.2	138.5	0.1	115.5	29.9	30.7	62.2	16.4	105.9	84.5	81.3	29.6	73.7	118.8	83.7	0.1	52.8	110.9	51.4	70.3	30.3	55.9	76.1	75.5	72.7	83.7	64.9	17.4	70.1	0.1	94.2	134.3	222.1	53.5	38.0	85.1	107.5	93.1	316.6	145.6	24.8	57.4	20.9	32.5	78.6	213.4	0.2	87.0	28.3	43.0	56.4	30.5	85.8	15.4	20.8	151.7	47.6	53.2	51.0	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6	131.0	259.8	264.1	356.5	64.9	144.4	2212.6	252.3	329.2	235.4	450.1	64.8	1548.4	2801.9	8.8	8.2	201.1	10.6	163.5	278.5	675.2	313.9	183.2	261.1	6.8	514.5	133.5	88.8	124.0	155.9	19.6	254.3	185.3	170.4	154.1	114.8	173.5	149.2	14.4	390.3	2766.7	85.3	232.8	418.6	17.7	95.7	56.1	1371.1	274.1	316.8	307.0
LDHC	CT32	ENSG00000166796	"Lactate dehydrogenase C"	P07864	11	18412307-18452058	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 143.9"	"Group enriched"	"Detected in some"	11	"Early spermatids: 838.5;Spermatocytes: 827.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 3.5;U-2197: 8.7;U-266/70: 7.8;U-266/84: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045442	Enhanced					NA	NA					"HPA045442: AB_10966720"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.93e-1)"	0.1	0.1	0.7	0.0	0.9	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.3	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.0	0.0	143.9	0.3	0.0	0.2	0.1	0.2	0.0	0.0	2.4	2.7	3.6	1.1	0.2	3.8	1.2	0.0	0.0	0.3	2.0	1.5	1.6	2.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.2	2.8	0.2	1.1	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.2	1.0	0.2	0.1	0.6	0.0	0.4	0.2	0.5	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	1.9	0.0	2.2	3.5	0.5	0.1	0.2	0.1	0.9	0.4	2.8	8.7	0.1	7.8	6.8	0.3	0.1	0.0	0.1	1.3	0.7	1.0	0.6	1.0	2.3	0.8	1.8	2.2	0.0	2.4	3.8	2.6	3.6	0.2	1.1	2.7	1.7	1.2	0.7	0.9	0.6	0.4	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.6	0.0	1.4	1.2	1.8	0.0	0.0	3.3	0.3	838.5	0.6	0.0	0.0	5.5	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.6	0.0	78.1	21.6	0.0	0.0	0.0	0.0	1.0	1.2	0.0	17.0	2.9	0.6	19.4	0.0	827.5	26.0	0.5	0.0	0.0	0.0	0.1
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116771	"Enzymes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3;skeletal muscle: 39.7"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 33.6;Enterocytes: 38.8;Hepatocytes: 81.8;Proximal tubular cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 8.9;classical monocyte: 2.7;intermediate monocyte: 4.6;non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 8.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 8.7;HMC-1: 12.0;T-47d: 23.5;U-266/70: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	15.3	5.5	6.8	1.6	6.7	0.8	3.7	4.9	11.7	4.1	12.5	7.6	4.5	6.1	1.5	3.0	3.8	2.1	3.6	25.3	6.6	5.8	21.5	44.3	2.8	0.9	8.1	9.7	7.9	7.7	8.5	4.4	2.1	9.9	4.4	6.8	5.1	14.2	4.5	39.7	1.8	2.5	1.2	4.5	0.7	11.2	1.0	4.0	0.0	4.3	14.4	2.7	1.1	1.2	0.0	0.2	8.9	5.7	0.1	0.1	0.9	0.6	1.6	0.0	0.3	1.3	1.1	5.1	0.1	0.1	0.1	0.2	2.1	2.2	0.0	1.8	0.7	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.7	2.1	0.0	12.0	1.6	0.3	0.0	0.0	0.4	0.1	0.3	0.6	1.9	0.0	4.0	0.0	0.6	1.1	2.1	1.0	0.0	0.0	6.0	1.1	0.1	0.0	0.0	0.0	4.1	0.3	0.6	23.5	2.6	0.0	0.0	0.2	0.0	0.0	9.3	0.5	0.0	1.6	0.0	0.0	8.9	2.7	0.8	0.0	4.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.9	6.8	6.7	4.9	11.7	6.6	5.8	8.1	9.7	9.9	4.0	0.0	7.9	2.2	2.1	0.6	0.0	33.6	10.2	1.4	1.2	10.4	0.0	1.6	31.5	1.3	0.3	0.6	38.8	0.0	5.5	1.1	0.5	1.6	10.3	81.8	6.2	1.6	2.9	4.3	5.3	0.2	0.0	1.6	5.0	1.0	9.4	11.0	3.7	19.9	0.0	75.5	1.0	0.0	0.4	0.0	0.3	0.3	2.6	1.3	11.0	1.7
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210389-83431071	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 57.7;Muller glia cells: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 15.6"	"Lineage enriched"	"Detected in many"	11	"T-cells: 15.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.9;OE19: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	30.7	35.3	16.3	4.6	17.7	0.8	27.1	5.5	13.1	5.9	6.7	5.4	39.2	18.1	3.8	7.4	24.5	4.2	13.5	21.3	10.5	14.0	3.6	12.4	7.7	6.0	16.8	11.8	10.0	3.3	30.0	11.1	2.9	16.3	7.9	10.1	9.3	7.8	30.2	25.7	10.1	8.7	18.7	17.2	6.3	20.0	13.4	7.2	1.4	6.3	20.9	4.5	13.7	14.9	0.0	0.0	0.0	1.4	0.0	15.6	0.5	8.8	18.3	0.4	0.0	15.6	14.6	0.0	5.7	14.7	6.1	11.9	42.9	7.8	0.0	15.0	13.4	12.2	9.3	13.6	5.1	6.7	0.0	7.6	0.0	11.7	0.0	20.0	4.3	16.1	15.9	10.3	12.3	8.4	10.3	9.5	0.0	6.1	0.0	8.3	9.9	0.0	4.9	0.0	48.5	7.2	0.0	15.4	8.5	18.1	4.2	1.8	4.7	9.7	14.4	0.3	8.3	0.0	10.6	10.0	3.8	4.6	1.2	0.0	3.4	3.9	0.0	0.0	0.0	11.2	0.0	1.4	0.0	0.8	0.3	15.6	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.3	17.7	5.5	13.1	10.5	14.0	16.8	11.8	16.3	7.2	17.9	8.9	0.0	4.2	1.6	16.7	35.8	5.1	1.4	6.8	5.2	2.0	0.5	1.7	10.0	4.4	1.9	8.0	0.0	8.4	0.6	7.1	5.6	0.0	12.4	6.8	12.7	0.0	4.9	57.7	4.2	23.9	9.5	0.0	5.4	4.0	93.9	12.7	5.8	35.0	2.6	6.4	0.0	3.3	4.9	1.5	3.0	0.7	0.9	5.5	1.8
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50878734-50954257	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria		NA	NA		3400000	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.6	18.1	17.1	18.4	16.2	11.6	10.7	13.2	16.0	9.4	26.4	14.3	16.8	30.2	10.5	7.7	10.6	9.3	10.5	34.6	15.8	17.8	12.1	12.1	10.3	24.1	18.7	14.0	11.1	16.7	20.6	20.2	10.5	47.7	11.8	26.6	9.4	8.8	23.1	29.5	7.1	44.8	16.9	18.9	36.6	20.3	15.3	8.7	24.3	9.0	7.8	17.3	14.2	15.7	4.9	9.6	14.3	17.4	6.7	6.0	4.5	13.0	13.1	17.5	20.4	8.0	8.9	8.1	10.9	8.2	14.3	12.1	6.0	7.2	46.7	4.3	9.7	13.1	10.9	26.1	11.1	16.5	19.3	4.0	11.9	8.3	7.0	23.6	39.6	14.3	5.5	13.6	18.0	29.3	9.4	18.3	27.8	12.6	11.4	9.7	2.7	28.6	3.9	11.7	9.4	5.4	18.8	8.7	13.5	15.6	2.8	21.7	11.5	10.2	6.3	10.9	11.0	4.8	19.3	11.3	10.2	11.4	5.3	14.5	21.3	8.6	22.9	10.3	28.3	10.8	5.0	11.6	14.3	5.0	13.1	4.1	4.9	3.3	6.0	9.6	4.9	2.9	3.5	13.3	6.7	17.4	3.2	3.1	4.5	17.1	16.2	13.2	16.0	15.8	17.8	18.7	14.0	47.7	8.7	8.9	11.0	34.0	15.3	13.5	17.4	93.2	7.6	5.3	26.1	14.0	13.7	14.6	33.2	28.0	13.4	14.8	44.5	0.0	34.2	14.5	10.8	15.2	15.1	7.4	87.2	7.9	11.5	30.7	83.1	4.7	10.6	39.2	11.8	27.9	24.3	13.0	27.5	20.1	15.6	14.0	55.9	6.5	15.4	50.9	20.4	9.4	7.2	26.1	35.2	14.8
ME3		ENSG00000151376	"Malic enzyme 3"	Q16798	11	86441108-86672636	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 48.7;Distal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.5;hTERT-RPE1: 29.4;HUVEC TERT2: 16.3;TIME: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038473	Approved					NA	NA					"HPA038473: AB_10672747"	"unprognostic (1.83e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.96e-2)"	"prognostic favorable (3.86e-4)"	17.2	15.9	16.0	6.3	27.7	5.8	13.1	15.7	26.1	19.3	14.3	4.8	7.3	7.8	15.8	7.6	5.0	9.0	12.9	21.9	12.2	13.1	12.6	3.9	8.1	4.3	12.5	18.1	22.1	16.7	28.5	15.4	5.4	20.2	13.0	15.0	11.5	13.6	10.3	21.2	3.0	7.1	15.6	5.5	7.3	20.8	8.8	8.4	2.8	8.2	6.3	2.9	10.3	10.2	0.0	5.0	0.0	0.9	2.2	3.1	1.0	0.0	8.2	2.3	0.0	3.7	7.8	0.0	2.8	4.3	5.8	7.4	6.2	24.5	0.0	2.5	2.6	14.7	0.1	0.0	0.0	2.6	4.3	0.0	4.2	6.8	0.0	5.5	0.5	0.0	5.4	1.2	4.7	0.0	29.4	16.3	0.0	0.0	0.0	3.8	0.8	1.1	0.0	0.5	0.7	3.4	3.6	0.0	0.3	5.2	9.5	2.8	0.0	1.7	0.0	0.0	1.0	0.4	0.6	18.1	0.7	0.5	12.2	0.4	0.0	1.5	0.0	0.6	7.6	0.7	0.0	0.9	0.0	1.9	0.1	0.0	0.0	1.9	3.1	5.0	0.0	2.3	2.7	0.0	2.2	0.3	0.6	0.0	1.0	16.0	27.7	15.7	26.1	12.2	13.1	12.5	18.1	20.2	8.4	3.0	3.5	0.8	4.4	2.1	15.2	48.7	5.1	17.4	4.5	3.5	0.0	0.1	36.5	6.9	0.5	8.3	11.0	0.0	6.9	0.3	3.9	5.3	0.0	0.5	6.9	19.1	8.6	11.1	1.8	1.3	5.8	2.5	1.7	1.8	11.2	1.7	8.3	9.3	6.0	5.5	2.3	12.9	3.7	0.3	0.2	1.4	0.0	1.3	9.3	6.0
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0.0	3.8	2.9	4.8	3.9	3.8	21.0	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0.0	5.9	21.0	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0.0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7.0	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4.0	3.7	4.7	2.1	2.0	2.3	0.0	4.1	2.9	3.4	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0.0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0.0	1.2	3.5	2.0	15.6	1.7	3.1	15.2	1.4	18.6	0.0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0.0	8.6	4.3	6.9	39.9	0.6	1.6	5.0	32.5	4.2	9.2	2.3	7.0	3.9	37.8	4.7	0.0	1.4	6.0	4.2	0.5	21.3	1.3	6.0	1.1
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568112	"Citric acid cycle related proteins, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 419.5"	"Cell type enhanced"	"Detected in many"	24	"Distal tubular cells: 499.0;Enterocytes: 868.1;Hepatocytes: 756.2;Proximal tubular cells: 2559.6"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"ASC diff: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		380000			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	10.0	0.1	0.4	2.2	0.4	0.0	11.1	0.2	0.6	0.1	52.0	0.2	0.1	19.2	0.1	0.7	0.2	0.1	5.6	0.4	0.3	0.2	72.0	419.5	0.2	0.3	0.2	0.2	0.4	0.2	0.0	5.0	0.1	0.5	0.2	14.0	0.2	0.2	0.1	0.3	0.1	58.5	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.4	0.4	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.6	0.3	0.2	0.2	0.2	0.5	0.2	0.0	0.0	9.5	0.0	0.1	0.2	0.3	30.6	0.0	1.2	85.5	0.0	0.0	499.0	0.3	0.0	0.1	868.1	0.0	0.0	0.0	0.2	0.0	9.2	756.2	0.0	3.2	51.8	23.4	17.7	0.0	0.0	0.0	0.0	0.0	182.0	8.0	0.1	241.9	0.0	2559.6	0.2	0.0	2.1	0.0	0.0	0.3	0.2	8.5	181.4	0.0
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 152.4;Hepatocytes: 291.7;Proximal tubular cells: 166.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.3;hTCEpi: 34.3;SK-MEL-30: 32.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.5	3.1	0.9	5.9	3.7	3.7	15.0	6.9	8.3	5.8	9.4	5.1	6.4	14.1	0.8	10.6	1.9	8.1	6.0	8.9	4.8	7.2	0.2	2.5	1.7	27.5	35.3	4.9	11.1	4.3	34.3	3.6	8.9	1.6	4.6	16.4	7.2	26.1	2.2	23.9	1.2	2.5	1.0	12.5	4.2	2.8	3.4	8.0	1.7	8.6	3.7	5.9	5.3	6.8	32.5	0.9	9.2	7.6	0.8	1.2	6.7	1.8	1.9	17.9	5.6	3.5	3.5	7.7	3.1	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3	11.9	22.0	24.4	8.8	3.0	4.1	1.2	20.4	2.7	3.4	17.4	0.0	3.4	29.9	17.2	49.9	3.5	152.4	0.0	67.0	11.6	5.3	6.8	1.1	291.7	56.2	0.0	8.7	10.4	15.0	15.5	3.1	14.5	6.8	29.7	43.0	5.6	27.0	63.4	2.8	166.4	5.4	0.0	5.1	8.6	0.9	4.3	2.5	9.6	63.5	11.9
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 8.3;Hepatocytes: 15.1;Late spermatids: 16.6;Proximal tubular cells: 43.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"K-562: 48.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA		2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	8.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.2	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Cell type enhanced"	"Detected in all"	5	"monocytes: 1878.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.9	210.9	42.5	50.3	51.2	57.5	35.1	88.9	207.7	142.9	144.6	59.3	101.0	62.4	90.0	166.4	106.4	119.5	134.4	181.0	112.0	109.5	63.5	38.2	106.1	49.1	35.6	49.5	82.5	52.2	84.3	110.0	45.2	185.5	84.1	32.1	9.5	50.1	225.2	50.9	18.5	21.3	52.6	125.8	80.5	55.0	136.1	118.9	189.6	105.5	44.2	48.3	116.0	71.6	90.9	74.7	50.2	36.1	65.4	162.8	89.0	159.0	161.3	64.4	90.9	55.0	200.4	82.0	159.4	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4	110.2	78.1	134.8	464.1	502.3	450.3	279.7	94.3	129.8	157.0	786.9	347.5	523.8	679.8	1147.1	307.8	224.6	361.4	70.0	528.2	1096.0	273.6	329.6	203.1	2.0	698.2	1005.9	270.8	71.2	307.3	1333.1	145.6	439.7	337.4	1878.3	130.3	624.4	887.7	231.5	252.1	165.5	510.0	122.9	245.6	32.6	84.3	340.0	481.5	163.0	247.6	730.1
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193379-83198932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	5.0	10.1	8.5	3.4	10.4	1.0	5.4	11.8	14.6	5.6	4.0	5.9	11.6	4.2	5.7	15.9	3.1	6.5	7.6	7.2	9.4	11.0	7.5	8.1	4.8	3.9	6.5	11.7	7.0	13.4	7.4	9.8	4.2	11.6	19.2	4.3	3.7	16.4	11.3	4.1	3.4	4.0	5.5	4.8	4.1	5.3	14.5	3.9	1.7	10.4	3.1	4.4	5.2	2.8	3.7	6.8	0.7	3.9	0.8	4.6	2.1	2.2	2.0	4.7	8.9	5.7	4.2	3.3	5.0	10.7	3.8	4.6	2.9	1.2	1.7	4.1	6.1	8.7	2.2	3.9	3.0	5.9	2.0	4.0	2.0	3.0	6.4	8.8	0.5	1.6	5.4	5.0	4.8	10.0	12.5	7.0	4.8	3.1	3.0	4.6	3.1	0.7	1.5	1.6	2.0	2.0	2.5	9.7	1.0	7.9	2.5	1.7	5.8	3.0	4.9	4.5	7.1	3.0	3.0	7.4	2.7	1.7	3.7	2.2	6.7	2.7	1.0	3.1	0.8	3.1	0.5	1.8	0.0	2.4	1.6	3.9	3.7	3.6	3.6	2.0	2.2	4.6	4.5	0.7	0.8	3.9	6.8	4.0	2.1	8.5	10.4	11.8	14.6	9.4	11.0	6.5	11.7	11.6	3.9	0.0	7.9	5.2	3.2	3.3	5.6	5.0	5.1	4.0	0.0	1.8	0.0	6.8	5.0	7.7	27.1	2.9	2.6	0.0	8.0	2.7	5.8	7.9	0.0	4.4	4.3	1.6	5.2	4.3	1.3	11.7	8.3	2.3	8.5	3.6	4.7	8.4	6.2	3.4	5.6	9.3	4.1	6.5	5.0	20.7	7.2	2.0	4.8	2.5	2.6	2.1
UEVLD	"Attp, UEV3"	ENSG00000151116	"UEV and lactate/malate dehyrogenase domains"	Q8IX04	11	18529609-18588747	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047134	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047134: AB_10960698"	"unprognostic (1.05e-1)"	"unprognostic (6.76e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (5.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.81e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	17.3	15.0	13.3	11.6	12.9	5.5	20.8	9.7	13.3	17.1	18.2	16.4	12.9	15.1	15.0	16.3	17.8	12.6	13.0	13.2	13.1	12.1	21.8	17.2	13.3	12.3	15.6	10.9	13.8	11.8	19.1	14.2	16.2	15.5	17.9	20.0	11.4	14.8	13.9	20.4	20.2	15.9	18.3	23.0	12.5	13.4	10.0	15.0	14.3	15.2	11.8	11.5	16.5	13.5	5.2	7.1	11.1	8.5	8.7	7.6	3.8	9.2	11.1	5.3	5.1	17.2	15.4	5.1	10.0	14.1	13.3	12.9	4.6	2.6	2.8	5.6	11.8	11.6	14.3	4.7	10.3	15.3	8.3	6.3	4.1	5.2	5.1	7.7	6.3	6.2	10.6	11.0	6.5	9.3	9.5	12.4	0.2	3.1	2.8	16.9	6.9	0.2	2.1	1.4	14.2	11.5	1.0	12.2	3.5	16.0	14.6	2.2	4.7	11.0	14.1	8.8	6.8	11.2	3.8	9.3	12.3	6.5	20.4	9.8	0.6	6.3	0.6	10.6	5.0	12.5	6.9	8.3	5.0	7.6	8.5	7.1	4.5	5.5	6.1	5.5	5.2	3.6	4.7	11.1	8.7	6.6	7.1	3.8	3.8	13.3	12.9	9.7	13.3	13.1	12.1	15.6	10.9	15.5	15.0	14.9	17.1	0.8	5.1	5.6	8.9	8.5	2.5	21.4	13.6	22.7	9.8	7.4	3.3	9.2	2.3	7.1	18.7	0.0	11.4	6.2	6.9	7.6	5.8	13.0	10.8	14.3	8.7	12.9	15.3	1.4	7.5	10.4	6.8	6.4	14.4	12.3	11.0	7.0	17.3	11.4	11.0	12.9	7.5	6.5	5.9	8.2	6.4	6.9	13.0	6.5
ZADH2	MGC45594	ENSG00000180011	"Zinc binding alcohol dehydrogenase domain containing 2"	Q8N4Q0	18	75195108-75209348	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021468, HPA053646"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA021468: AB_1858932, HPA053646: AB_2682216"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.79e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.02e-6)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (2.23e-1)"	14.1	12.1	15.6	12.5	22.5	12.7	28.1	19.1	24.1	15.5	18.9	10.8	13.6	13.7	12.8	19.0	18.1	13.5	15.7	24.4	17.4	11.3	18.0	23.4	13.3	12.7	12.9	18.4	19.6	19.5	22.4	20.5	26.2	19.3	13.8	21.4	13.5	16.3	14.1	34.5	15.8	24.0	16.9	12.1	15.0	15.5	7.1	11.2	11.2	20.7	15.5	14.5	17.4	15.5	2.7	3.3	12.1	5.2	2.5	4.8	2.3	9.4	6.3	6.7	13.8	10.5	13.6	7.4	17.2	20.0	6.8	8.5	3.8	13.5	6.6	2.8	17.0	8.0	12.9	8.3	14.5	4.8	41.3	12.2	14.9	13.9	7.5	7.5	25.1	15.2	15.0	14.6	5.4	12.5	12.6	13.9	15.8	8.0	24.5	12.9	11.1	6.3	12.4	1.7	9.2	14.4	13.5	10.8	21.9	13.2	16.1	12.5	10.3	9.5	9.8	10.9	5.0	9.8	12.5	12.3	13.4	10.2	4.2	5.4	4.0	17.4	4.5	8.8	21.8	10.7	1.9	5.0	12.1	4.8	4.2	3.8	2.7	4.1	4.5	3.3	2.5	2.3	3.5	2.7	2.5	5.2	2.5	4.4	2.3	15.6	22.5	19.1	24.1	17.4	11.3	12.9	18.4	19.3	11.2	32.8	14.1	10.4	16.0	8.7	56.1	45.6	17.8	5.3	10.3	26.2	5.9	8.2	16.6	10.1	0.4	23.3	27.4	0.0	18.6	5.9	16.9	16.0	6.9	20.7	14.3	23.8	22.5	19.6	18.6	1.1	33.9	14.8	11.8	14.4	25.7	20.9	12.7	21.0	59.4	14.6	39.1	19.4	9.8	0.3	6.3	9.7	5.6	10.0	27.0	18.3
